Cleveland Jewish News: William Schiemann, associate professor of general medical sciences, led a team of researchers who found a link between a micro ribonucleic acid molecule and late-stage breast cancer. “Our micro RNA inactivates [a protein called] Bim, and we think this leads to chemo resistance to these metastatic cancers,” Schiemann said. Lower Bim levels, coupled with higher miR-181a levels, allow the spread of cancer.
Medicine’s William Schiemann and researchers target molecule’s role in late-stage breast cancer
- New Nord Family Greenway profiled in “Architect Magazine”
- Distinguished University Professor Richard Boyatzis weighs in on research suggesting emotions can be spread from person to person
- Music’s David Rothenberg previews The Cleveland Orchestra’s performance of Dvorak’s Stabat Mater
- PRCHN’s Darcy Freedman discusses Future of Food in Your Neighborhood Study
- Collegiate Inventors Competition accepting applications through June 1